Effect of glutathione on prognosis of liver cirrhosis patients with massive upper gastrointestinal hemorrhage

Shui-xiang HE,Han FU,Yan-li WANG,Ying-ren ZHAO,Xin-ming CHANG
DOI: https://doi.org/10.3969/j.issn.1005-8982.2005.16.001
2005-01-01
Abstract:[Objective] To study the effects of glutathione on the prognosis of liver cirrhosis patients with massive upper gastrointestinal hemorrhage. [Methods] After the patients were treated with glutathione (1.2~1.6 g/d, iv.) for 4weeks, the glutathione (GSH) level in blood, the glutathione peroxidase (GSH-Px) activity and the lipid peroxide (MDA) level in plasma were determined. Meanwhile, the clinical significance of glutathione therapy on the patients was observed. [Results] The GSH level and GSH-Px/MDA ratio in all patients were decreased significantly after bleeding. The lowest point of the GSH level and GSH-Px/MDA ratio were observed at 72 h after bleeding, while the GSH level and GSH-Px/MDA ratio in patients treated with glutathione were higher than those in controls (GSH,(1.75±0.25) vs (1.15±0.20), P <0.01; GSH-Px/MDA, (0.11±0.03) vs (0.07±0.02), P <0.01). The recovery changes were observed at 2 w after bleeding. A better prognosis correlating with Child-Pugh degree was noticed in patients treated with glutathione, too. [Conclusion] The antioxidative capability of patients with liver cirrhosis is decreased after massive upper gastrointestinal hemorrhage, and glutathione therapy could increase the patients GSH-Px/MDA ratio and improve their prognosis.
What problem does this paper attempt to address?